ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,480,000 | -80.7% | 455,000 | -57.9% | 0.00% | -80.0% |
| Q2 2019 | $12,865,000 | +133.4% | 1,082,000 | +2.9% | 0.01% | +150.0% |
| Q1 2019 | $5,512,000 | +66.3% | 1,052,000 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $3,314,000 | -34.4% | 1,052,000 | +26.0% | 0.00% | 0.0% |
| Q3 2018 | $5,052,000 | +89.4% | 835,100 | +65.9% | 0.00% | +50.0% |
| Q2 2018 | $2,668,000 | -8.6% | 503,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,920,000 | +65.7% | 503,400 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,762,000 | -0.3% | 503,400 | +3.9% | 0.00% | 0.0% |
| Q3 2017 | $1,768,000 | +44.1% | 484,500 | -1.3% | 0.00% | 0.0% |
| Q2 2017 | $1,227,000 | +3.2% | 490,700 | +11.4% | 0.00% | 0.0% |
| Q1 2017 | $1,189,000 | -3.6% | 440,400 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $1,234,000 | -29.6% | 425,600 | -0.2% | 0.00% | -50.0% |
| Q3 2016 | $1,752,000 | +30.7% | 426,300 | +0.6% | 0.00% | +100.0% |
| Q2 2016 | $1,340,000 | – | 423,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |